(S)-1-{1-[1-(2-amino-9H-purin-6-yl)piperidin-4-yl]-1H-1,2,3-triazol-4-yl}ethanol

Term ID

CHEBI:156220

Synonyms

(1S)-1-{1-[1-(2-amino-9H-purin-6-yl)piperidin-4-yl]-1H-1,2,3-triazol-4-yl}ethan-1-ol
(1S)-1-{1-[1-(2-amino-9H-purin-6-yl)piperidin-4-yl]-1H-1,2,3-triazol-4-yl}ethanol
(alphaS)-1-[1-(2-amino-9H-purin-6-yl)-4-piperidinyl]-alpha-methyl-1H-1,2,3-triazole-4-methanol
(S)-1-(1-(1-(2-amino-9H-purin-6-yl)piperidin-4-yl)-1H-1,2,3-triazol-4-yl)ethanol
DB-15
DB15

Definition

Piperidine carrying a 2-amino-9H-purin-6-yl group on nitrogen and a 4-[(1S)-1-hydroxyethyl]-1H-1,2,3-triazol-1-yl substituent on N-4. One of a series of mucosal-associated invariant T (MAIT) cell agonists.

References

PMID:32341160

Ontology

ChEBI ( EBI )

Relationships

is a type of: piperidines

piperidines Show first 5 Terms
has_parent_hydride: 1H-1,2,3-triazole 9H-purine

1H-1,2,3-triazole 9H-purine Show first 5 Terms

Phenotype

Phenotype resulting from (S)-1-{1-[1-(2-amino-9H-purin-6-yl)piperidin-4-yl]-1H-1,2,3-triazol-4-yl}ethanol

Phenotype where environments contain (S)-1-{1-[1-(2-amino-9H-purin-6-yl)piperidin-4-yl]-1H-1,2,3-triazol-4-yl}ethanol

Phenotype modified by environments containing (S)-1-{1-[1-(2-amino-9H-purin-6-yl)piperidin-4-yl]-1H-1,2,3-triazol-4-yl}ethanol

Human Disease Model